PMID- 23841525
OWN - NLM
STAT- MEDLINE
DCOM- 20141028
LR  - 20221207
IS  - 1463-1326 (Electronic)
IS  - 1462-8902 (Linking)
VI  - 16
IP  - 1
DP  - 2014 Jan
TI  - Application of the International Diabetes Federation and American Diabetes 
      Association criteria in the assessment of metabolic control after bariatric 
      surgery.
PG  - 86-9
LID - 10.1111/dom.12177 [doi]
AB  - The International Diabetes Federation (IDF) and the American Diabetes Association 
      (ADA) have introduced specific criteria to define the 'optimization' of the 
      metabolic state and glycaemic 'remission' of type 2 diabetes mellitus (T2DM) 
      after bariatric surgery, respectively. Our objective was to assess the percentage 
      of patients achieving these criteria. Data were collected for body mass index, 
      glycaemic markers, lipids, blood pressure, hypoglycaemia and medication usage 
      from 396 morbidly obese T2DM patients who underwent bariatric surgery in two 
      centres and followed up for 2 years. At year 1, 14% of patients achieved the IDF 
      criteria and 38% the ADA criteria, whereas at 2 years 8 and 9% satisfied these 
      criteria, respectively. A relatively low proportion of patients achieved 
      optimization of the metabolic state and T2DM remission. These patients may 
      potentially benefit from the combination of bariatric surgery and adjuvant 
      medical therapy to achieve optimal metabolic outcomes.
CI  - (c) 2013 John Wiley & Sons Ltd.
FAU - Miras, A D
AU  - Miras AD
AD  - Investigative Science, Imperial College London, Hammersmith Hospital, London, UK.
FAU - Risstad, H
AU  - Risstad H
FAU - Baqai, N
AU  - Baqai N
FAU - Law, S
AU  - Law S
FAU - Sovik, T T
AU  - Sovik TT
FAU - Mala, T
AU  - Mala T
FAU - Olbers, T
AU  - Olbers T
FAU - Kristinsson, J A
AU  - Kristinsson JA
FAU - le Roux, C W
AU  - le Roux CW
LA  - eng
GR  - G0902002/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130819
PL  - England
TA  - Diabetes Obes Metab
JT  - Diabetes, obesity & metabolism
JID - 100883645
RN  - 0 (Biomarkers)
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - *Bariatric Surgery
MH  - Biomarkers/blood
MH  - Blood Glucose/*metabolism
MH  - Body Mass Index
MH  - Diabetes Mellitus, Type 2/*blood/surgery
MH  - Female
MH  - Glycated Hemoglobin/*metabolism
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/*blood/surgery
MH  - Remission Induction
MH  - Risk Assessment
MH  - Treatment Outcome
MH  - Weight Loss
OTO - NOTNLM
OT  - bariatric surgery
OT  - obesity therapy
OT  - type 2 diabetes
EDAT- 2013/07/12 06:00
MHDA- 2014/10/29 06:00
CRDT- 2013/07/12 06:00
PHST- 2013/05/25 00:00 [received]
PHST- 2013/06/11 00:00 [revised]
PHST- 2013/07/04 00:00 [accepted]
PHST- 2013/07/12 06:00 [entrez]
PHST- 2013/07/12 06:00 [pubmed]
PHST- 2014/10/29 06:00 [medline]
AID - 10.1111/dom.12177 [doi]
PST - ppublish
SO  - Diabetes Obes Metab. 2014 Jan;16(1):86-9. doi: 10.1111/dom.12177. Epub 2013 Aug 
      19.